Frost & Sullivan Research Service   Published: 9 Jan 2017
2016 Global Survey on Clinical Next-Generation Sequencing
  SERVICE HOMEPAGE
FURTHER INFORMATION
  Table Of Contents
  1 | 2016 GLOBAL SURVEY ON CLINICAL NEXT-GENERATION SEQUENCING
   Executive Summary
      1. Key Findings

  Research Background, Objectives, Methodology, and Respondent Demographics
      1. Research Objectives
      2. Research Methodology
      3. Research Methodology (continued)

  Demographics
      1.  Technology Usage and Outsourced Respondents
      2. Respondent Demographics
      3. Respondent Demographics (continued)

  Brand Familiarity of Clinical NGS Providers
      1. Brand Perception of Top 16 Providers

  NGS Clinical Applications
      1. Current and Future Interest Areas for Clinical NGS Testing
      2. Top 7 Preferred Vendors for NGS Clinical Sequencing Services
      3. Areas of Pathogen Clinical Research and Methodology Used

  NGS for Infectious Disease Testing
      1. Interest in Pursuing NGS-based Infectious Disease Testing
      2. Current and Future Plans in Infectious Disease Testing
      3. Brand Familiarity for Infectious Disease Testing
      4. Sequencing Methods Used for Testing
      5. Infectious Disease Sequencing Method
      6. Genetic Elements of Interest for NGS Clinical Work
      7. Correlation of Genetic Elements and Clinical Area of Interest
      8. Correlation of Genetic Elements and Sequencing Methods

  Instrument and Reagent Purchase Patterns
      1. Instrument and Reagent Purchase Patterns
      2. Instrument and Reagent Purchase Patterns (continued)
      3. Complemented or Replaced Instruments in Labs
      4. Complementing Instruments/Methods
      5. Instrument Usage—Current and Future Use for Clinical Applications
      6. Analysis of Instruments and Clinical Applications

  Clinical NGS Data Analysis
      1. NGS Data Analysis
      2. Data Analysis for Specific Infectious Disease NGS Application
      3. Current and Future Usage of NGS Informatics Platforms
      4. Factors Promoting Adoption of Clinical NGS
      5. Factors Limiting the Adoption of Clinical NGS
      6. Factors that Helped Overcome Obstacles to Implementing NGS
      7. Legal Disclaimer

  Appendix
      1. Additional Sources of Information

  The Frost & Sullivan Story
      1. The Frost & Sullivan Story
      2. Value Proposition—Future of Your Company & Career
      3. North America and Europe Perspective
      4. Industry Convergence
      5. 360º Research Perspective
      6. Implementation Excellence
      7. Our Blue Ocean Strategy

Conseq